Moderna rises after first-quarter revenue beats estimates

Moderna

01/05/2026 11:34

** Shares of vaccine maker Moderna MRNA.O rise 4.7% to $48.03 premarket

** Moderna posts Q1 revenue of $389 million, above analysts' estimates of $228 million - data compiled by LSEG

** Co reports loss per share of $3.40 vs estimated loss per share of $3.96

** Moderna reiterated its expectation for full-year revenue growth of up to 10% in 2026 compared with a year ago

** Up to last close, stock up 55.8% YTD

(Reporting by Siddhi Mahatole)

((siddhi.mahatole@thomsonreuters.com))